Sail Biomedicines: Wendy Chung

Wendy Chung has joined the board of directors of Sail Biomedicines, a company developing RNA-based programmable therapeutics. She is chief of the department of pediatrics at Boston Children's Hospital, a faculty member at Harvard Medical School, and president of the Children's Hospital Pediatric Associates. She is also principal investigator of the GUARDIAN newborn study that is testing the utility of whole-genome sequencing for newborn screening.